Science Explorer Back to mapMap
Discussion
Researcher · MRIGlobal · United States

Jeremy T. Boone

Jeremy T. Boone publishes mostly in Molecular Biology, Infectious Diseases and Genetics, on topics such as Animal Genetics and Reproduction, Xenotransplantation and immune response and CRISPR and Genetic Engineering.

OpenAlex
World rank
#2,591,138
of 7,710,434 ranked researchers
Rank in United States
#760,385
of 1,627,098
Works
15
Citations
3.3k
Citations per work
219.0
h-index
9
i10-index 8Top 82% in Molecular Biology
Jeremy T. Boone

What does Jeremy T. Boone research?

Jeremy T. Boone's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (39%).

Health Sciences: 6 works · 40.9% of their workMedicine: 6 works · 40.9% of their workInfectious Diseases: 3 works · 20.5% of their workSurgery: 2 works · 11.4% of their workNeurology: 1 works · 4.5% of their workPublic Health, Environmental and Occupational Health: 1 works · 4.5% of their workLife Sciences: 6 works · 38.7% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 38.7% of their workMolecular Biology: 3 works · 20.5% of their workGenetics: 3 works · 18.2% of their workEverything else: 3 works · 20.4% of their workTHEIR WORKJeremy T. Boone15works
Life Sciences39%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine640.9%
    1. Biochemistry, Genetics and Molecular Biology638.7%
  3. Everything else320.4%
  1. 1Molecular Biology20% of their works
  2. 2Infectious Diseases20% of their works
  3. 3Genetics18% of their works
  4. 4Surgery11% of their works
  5. 5Neurology4% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Jeremy T. Boone's research?

The keywords of their largest research topics: Biopharmaceutical Production, Genetic Modification, SARS-CoV-2, Transgenic Animals, ACE2 Receptor, Pig-to-Human Transplantation, Vaccine and Xenotransplantation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Biopharmaceutical Production102 topics
  2. Genetic Modification71 topic
  3. SARS-CoV-273 topics
  4. Transgenic Animals71 topic
  5. ACE2 Receptor52 topics
  6. Pig-to-Human Transplantation51 topic
  7. Vaccine52 topics
  8. Xenotransplantation51 topic
  9. Epidemiology42 topics
  10. Coronavirus31 topic
  11. Genome Engineering31 topic
  12. Mammalian Cells31 topic
  13. RNA-Guided31 topic
  14. Recombinant Protein31 topic
  15. spike protein31 topic
  16. COVID-1921 topic
  17. Clinical Characteristics21 topic
  18. Diagnostics21 topic
  19. Norovirus21 topic
  20. Rotavirus21 topic
  21. Thrombosis21 topic

Where does Jeremy T. Boone work?

Jeremy T. Boone's main affiliation in the publication record is MRIGlobal, United States.

How many publications and citations does Jeremy T. Boone have?

OpenAlex counts 15 works and 3,285 citations for Jeremy T. Boone, an h-index of 9, ranking #2,591,138 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeremy T. Boone. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.